Literature DB >> 1991038

Avidin acylation prevents the complement-dependent lysis of avidin-carrying erythrocytes.

V R Muzykantov1, M D Smirnov, G P Samokhin.   

Abstract

Non-covalent binding of avidin to biotinylated erythrocytes results in complement-dependent haemolysis. Biotinylated erythrocytes, as well as native cells, are not lysed by complement. Complement activation requires a tight contact between avidin and the erythrocyte membrane, since avidin does not in itself activate complement and does not inhibit lysis of sensitized sheep erythrocytes. The efficiency of haemolysis depends on avidin's surface density. When the avidin concentration in the reaction mixture is less than 15 micrograms/ml, erythrocyte lysis is not induced. However, the attachment of biotinylated antibodies to avidin-carrying erythrocytes decreases dramatically. Acylation of avidin with succinic anhydride strongly decreases its ability to induce complement-dependent haemolysis. However, the ability of avidin to cross-link the biotin-containing structures decreases after acylation. A 50% modification of avidin by succinic anhydride (pI about 7.0) allows preparation of 'immunoerythrocytes', which retain their affinity to antigen and stability in the presence of complement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991038      PMCID: PMC1149858          DOI: 10.1042/bj2730393

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

Review 1.  The avidin-biotin complex in bioanalytical applications.

Authors:  M Wilchek; E A Bayer
Journal:  Anal Biochem       Date:  1988-05-15       Impact factor: 3.365

2.  Blood clearance of radiolabeled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies.

Authors:  A L Klibanov; A V Martynov; M A Slinkin; M D Smirnov; V R Muzykantov; S M Danilov; V P Torchilin
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

3.  Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall.

Authors:  V N Smirnov; S P Domogatsky; V V Dolgov; V B Hvatov; A L Klibanov; V E Koteliansky; V R Muzykantov; V S Repin; G P Samokhin; B V Shekhonin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Investigations of avidin and biotin for imaging applications.

Authors:  D J Hnatowich; F Virzi; M Rusckowski
Journal:  J Nucl Med       Date:  1987-08       Impact factor: 10.057

5.  Hemolytic complement activity assay in microtitration plates.

Authors:  V R Muzykantov; G P Samokhin; M D Smirnov; S P Domogatsky
Journal:  J Appl Biochem       Date:  1985-06

6.  Targeting of enzyme immobilized on erythrocyte membrane to collagen-coated surface.

Authors:  V R Muzykantov; D V Sakharov; M D Smirnov; S P Domogatsky; G P Samokhin
Journal:  FEBS Lett       Date:  1985-03-11       Impact factor: 4.124

Review 7.  Molecular basis of complement deficiency syndromes.

Authors:  H R Colten
Journal:  Lab Invest       Date:  1985-05       Impact factor: 5.662

Review 8.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

Review 9.  Pharmacological manipulation of complement system.

Authors:  S S Asghar
Journal:  Pharmacol Rev       Date:  1984-12       Impact factor: 25.468

10.  Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot.

Authors:  V R Muzykantov; D V Sakharov; M D Smirnov; G P Samokhin; V N Smirnov
Journal:  Biochim Biophys Acta       Date:  1986-11-19
View more
  7 in total

Review 1.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 2.  Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.

Authors:  Carlos H Villa; Douglas B Cines; Don L Siegel; Vladimir Muzykantov
Journal:  Transfus Med Rev       Date:  2016-08-17

Review 3.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

4.  Cyclic arginine-glycine-aspartic acid-modified red blood cells for drug delivery: Synthesis and in vitro evaluation.

Authors:  Chen Wang; Min Wang; Yan Zhang; Hongxin Jia; Binbin Chen
Journal:  J Pharm Anal       Date:  2021-06-12

Review 5.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07

6.  Chemical linkage to injected tissues is a distinctive property of oxidized avidin.

Authors:  Rita De Santis; Anna Maria Anastasi; Angela Pelliccia; Antonio Rosi; Claudio Albertoni; Antonio Verdoliva; Fiorella Petronzelli; Valeria D'Alessio; Serenella Serani; Carlo Antonio Nuzzolo
Journal:  PLoS One       Date:  2011-06-20       Impact factor: 3.240

7.  The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells.

Authors:  Daniel Pan; Omayra Vargas-Morales; Blaine Zern; Aaron C Anselmo; Vivek Gupta; Michael Zakrewsky; Samir Mitragotri; Vladimir Muzykantov
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.